Comparison Among Erythropoietin Stimulating Agents

NCT02049346 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

327

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia of End Stage Renal Disease

Interventions

DRUG: Epoetin alpha or beta (Epoetin group)
DRUG: Darbepoetin alfa
DRUG: Methoxy polyethylene glycol-epoetin beta

Sponsor

Hamad Medical Corporation